|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:approves
|
gptkb:2005
|
|
gptkbp:brand
|
gptkb:Daytrana
gptkb:Concerta
gptkb:Ritalin
|
|
gptkbp:category
|
gptkb:C
|
|
gptkbp:class
|
gptkb:pharmaceuticals
|
|
gptkbp:clinical_trial
|
ADHD treatment
narcolepsy treatment
|
|
gptkbp:condition
|
narcolepsy
|
|
gptkbp:contraindication
|
gptkb:Ophthalmology
heart problems
hyperthyroidism
|
|
gptkbp:dosage_form
|
gptkb:capsule
|
|
gptkbp:duration
|
8 to 12 hours
|
|
gptkbp:financial_support
|
take with food
do not crush or chew
monitor for mood changes
may cause dependency
|
|
gptkbp:form
|
gptkb:tablet
suspension
extended-release capsule
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ritalin LA
|
|
gptkbp:ingredients
|
gptkb:Sannin
|
|
gptkbp:interacts_with
|
antidepressants
MAO inhibitors
antihypertensives
|
|
gptkbp:invention
|
gptkb:2020
|
|
gptkbp:legal_status
|
prescription only
|
|
gptkbp:lifespan
|
3 to 4 hours
|
|
gptkbp:manufacturer
|
gptkb:Novartis
|
|
gptkbp:marketed_as
|
gptkb:Australia
gptkb:Canada
gptkb:UK
gptkb:United_States
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:performance
|
gptkb:II
|
|
gptkbp:premiered_on
|
1 to 2 hours
|
|
gptkbp:previous_name
|
yes
|
|
gptkbp:requires
|
available online
|
|
gptkbp:route_of_administration
|
oral
|
|
gptkbp:side_effect
|
headache
cardiovascular issues
insomnia
nervousness
skin rash
tics
loss of appetite
psychiatric symptoms
growth suppression
stomach ache
|
|
gptkbp:strength
|
10 mg
20 mg
30 mg
|
|
gptkbp:structure
|
C14 H19 NO2
|
|
gptkbp:used_for
|
ADHD
|
|
gptkbp:bfsParent
|
gptkb:Sannin
|
|
gptkbp:bfsLayer
|
5
|